ELVN

Enliven TherapeuticsB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

RSI (14)

33.4

Neutral

MACD Hist

-0.67

Bearish

ATR (14)

2.17

Normal

Vol Z (20)

3.28

Elevated

RET 20D

-14.6%

Negative

Dist 52W High

-26.2%

Below High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-06-02

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Mixed trend (SMAs not aligned)

Momentum

Short-term pullback vs positive 3M trend · 20D -14.6% · 60D +19.5%

RSI / MACD

RSI 33.4 (Neutral) · MACD hist -0.67

Volatility

Volatility elevated (Z 3.28)

SMA20

40.82

SMA50

41.32

SMA200

27.07

EMA12

39.86

EMA26

40.61

BB Upper

44.48

BB Mid

40.82

BB Lower

37.16

RET 5D

-14.2%

RET 20D

-14.6%

RET 60D

+19.5%

RET 120D

+82.2%

As of 2026-06-02 • Updated nightlySource: Internal modelMethodology